Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Francisco C A Mello"'
Reconstruction of the spatial and temporal dynamics of hepatitis B virus genotype D in the Americas.
Autor:
Natália Spitz, Francisco C A Mello, Aline S Moreira, Carolina S Gusatti, Regina M B Martins, Selma A Gomes, Gonzalo Bello, Natalia M Araujo
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0220342 (2019)
Hepatitis B virus (HBV) genotype D (HBV/D) is globally widespread, and ten subgenotypes (D1 to D10) showing distinct geographic distributions have been described to date. The evolutionary history of HBV/D and its subgenotypes, for which few complete
Externí odkaz:
https://doaj.org/article/8ed4daa7dfb7412dbf9f6134eac0aa32
Autor:
Francisco C. A. Mello, Tairine M. Barros, Giovana P. Angelice, Vanessa D. Costa, Vinicius M. Mello, Maria Inês M. C. Pardini, Elisabeth Lampe, Barbara V. Lago, Livia M. Villar
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Hepatitis D virus (HDV) is classified into 8 genotypes (1 to 8) and several subgenotypes. In Brazil, HDV-3 and HDV-1 predominate; however, most of the diagnosis efforts and molecular studies are directed to the area of endemicity of the Amaz
Externí odkaz:
https://doaj.org/article/637713d893514cae84ff5999be8b674a
Autor:
Francisco C. A. Mello, Marco Aurélio Pereira Horta, Isabel Inês M. de Pina-Araujo, Caroline Cordeiro Soares
Publikováno v:
Archives of Virology. 166:1345-1353
Human pegivirus 1 (HPgV-1) belongs to the genus Pegivirus, family Flaviviridae, and until now has been considered a non-pathogenic agent, despite being considered a risk factor for non-Hodgkin lymphoma. However, a beneficial impact of HPgV-1 on HIV d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3fc0fbf2d37b2676dbc35fdadc24168
https://doi.org/10.1007/s00705-021-05014-0
https://doi.org/10.1007/s00705-021-05014-0
Autor:
Vanessa D. Costa, Patricia Pellegrini, Vivian Rotman, Ana Maria Pittella, Estevão P. Nunes, Barbara V. Lago, Elisabeth Lampe, Francisco C. A. Mello
Publikováno v:
Viruses, Vol 11, Iss 11, p 1004 (2019)
In Brazil, hepatitis C treatment has been evolving significantly with the licensing of direct-acting antivirals (DAAs). However, viral determinants (amino acid substitutions in hepatitis C virus (HCV) genome and infective genotype) associated with ho
Externí odkaz:
https://doaj.org/article/6c0c3fe159814d72a4952875537f16c8
Autor:
Barbara V. Lago, Marcia P. do Espirito-Santo, Vanessa D. Costa, Vanessa A. Marques, Livia M. Villar, Lia L. Lewis-Ximenez, Elisabeth Lampe, Francisco C. A. Mello
Publikováno v:
Viruses, Vol 11, Iss 9, p 860 (2019)
Hepatitis B virus (HBV) subgenotypes may be related to clinical outcomes and response to antiviral therapy. Most Brazilian studies on HBV subgenotypes are restricted to some regions and to specific population groups. Here, we provide an insight about
Externí odkaz:
https://doaj.org/article/eae315cab7644ec99cb3c0693ebc75ba
Autor:
Rafael Brandão Varella, T Matuck, Caroline Cordeiro Soares, Flavia Savassi-Ribas, Tereza Cristina Simão Wagner, Deise De Boni Monteiro de Carvalho, Marco Aurélio Pereira Horta, Jéssica Gonçalves Pereira, Francisco C. A. Mello
Publikováno v:
Journal of Medical Virology. 92:2961-2968
Kidney transplantation is the treatment of choice for patients with end-stage renal disease. In the posttransplant period, the induced immunosuppression leads to an increased risk of developing infectious diseases, a leading cause of death after kidn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64c072b5d331e1833a3a3a5c05a06066
https://doi.org/10.1002/jmv.25764
https://doi.org/10.1002/jmv.25764
Autor:
Vinicius M. Mello, Lucas M. Bianchi, Paulo Sergio F. Sousa, Pedro S. Tavares, Daniel R. G. Di Salvo, Cleber F. Ginuino, Nathalia A. A. Almeida, Carlos A. S. Fernandes, Francisco C. A. Mello, Livia M. Villar, Lia L. Lewis-Ximenez, Barbara V. Lago
Publikováno v:
Viruses; Volume 14; Issue 2; Pages: 303
This study aims to evaluate the epidemiological and molecular features associated with HAV transmission in adults in Rio de Janeiro during a period of increased registered cases of HAV (2017–2018). Socio-epidemiological data and serum samples from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f237a14c9a92787eaf1d550ea39e658
Autor:
Vanessa Duarte da Costa, Paulo Sergio Fonseca de Sousa, Carlos Eduardo Brandão-Mello, Lia Laura Lewis Ximenez de Souza Rodrigues, Elisabeth Lampe, Francisco C. A. Mello, Estevão Portela Nunes, Nathália Delvaux
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology. 43:700-706
Summary Background and aims Treatment for hepatitis C has evolved significantly with the licensing of direct-acting antiviral drugs (DAAs). However, one of the limiting factors of the effectiveness of antiviral therapy with protease inhibitors (PIs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6554bcf5174fea8849730829a36c694
https://doi.org/10.1016/j.clinre.2019.02.009
https://doi.org/10.1016/j.clinre.2019.02.009
Autor:
Francisco José Dutra Souto, Cor Jesus Fernandes Fontes, Paulo Antonio Ferreira-Junior, Lucas José da Silva, Elaine Cristina de-Oliveira, Eduardo Rodrigues Alves-Junior, Thamires Oliveira Gasquez Martin, Francisco C. A. Mello
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical
Revista da Sociedade Brasileira de Medicina Tropical, Volume: 53, Article number: e20190559, Published: 21 OCT 2020
Revista da Sociedade Brasileira de Medicina Tropical v.53 2020
Sociedade Brasileira de Medicina Tropical (SBMT)
instacron:SBMT
Revista da Sociedade Brasileira de Medicina Tropical, Vol 53 (2020)
Revista da Sociedade Brasileira de Medicina Tropical, Volume: 53, Article number: e20190559, Published: 21 OCT 2020
Revista da Sociedade Brasileira de Medicina Tropical v.53 2020
Sociedade Brasileira de Medicina Tropical (SBMT)
instacron:SBMT
Revista da Sociedade Brasileira de Medicina Tropical, Vol 53 (2020)
INTRODUCTION: Brazil’s western Amazon basin has the highest prevalence of hepatitis B virus (HBV) infection in the country. Coinfection with hepatitis D virus (HDV) is also endemic. To estimate the prevalence of HBV and HDV markers in a population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e759480fcfd0b7e23f336601372835
http://europepmc.org/articles/PMC7580271
http://europepmc.org/articles/PMC7580271
Autor:
Adolfo Vubil, Lia Lewis, Vanessa Duarte, Ilesh V. Jani, Francisco C. A. Mello, Nédio Mabunda, Barbara Vieira do Lago, Jason T. Blackard, Nália Ismael, Milton Ozório Moraes, Ana Flora Zicai
Publikováno v:
Memórias do Instituto Oswaldo Cruz
Memórias do Instituto Oswaldo Cruz., Vol 115 (2020)
Memórias do Instituto Oswaldo Cruz, Volume: 115, Article number: e200006, Published: 23 SEP 2020
Memórias do Instituto Oswaldo Cruz., Vol 115 (2020)
Memórias do Instituto Oswaldo Cruz, Volume: 115, Article number: e200006, Published: 23 SEP 2020
BACKGROUND Occult hepatitis B virus (HBV) - characterized by the absence of detectable HBsAg in the presence of HBV DNA - represents a potential threat for blood safety. OBJECTIVES This study was conducted with the aim to investigate the serological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f0651f8101087486a00e6909f9f535c
http://europepmc.org/articles/PMC7523502
http://europepmc.org/articles/PMC7523502